Long antibodies better against HIV

Understanding how antibodies with long “loops” form may be important for HIV vaccine development.

Insights for neuroscience drug discovery

When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.

Childhood cancer investigator lands ‘Lemonade Stand’ grant

Chin Chiang, Ph.D., professor of Cell and Developmental Biology and member of the Vanderbilt-Ingram Cancer Center faculty, has been awarded a $200,000 grant to study an aggressive form of childhood cancer.

VU leading international trial of new stroke therapy

Researchers at Vanderbilt University Medical Center are leading an international clinical trial to examine the functional benefits of a combined therapy to treat acute ischemic stroke.

New cancer drug shows promise in early testing

Gene’s impact on ‘good’ cholesterol could affect heart disease risk

A genetic variant may help keep an individual’s “good” cholesterol in check.